Bookmark and Share

Micro-Cap in Focus; TrovaGene Inc. (TROV)

Shares of TrovaGene Inc. (NASDAQ: TROV), a developer of patented technology for the detection of transrenal DNA and RNA, have risen sharply in trading today.

At last check, TROV shares were trading 15.38% higher at $3.75 on above average volume of 146,792. The stock touched an intra-day high of $3.80 today.

Last week, TrovaGene announced the full exercise of the over-allotment option granted to its underwriters to purchase 172,500 additional units at a public offering price of $8 per unit. The over-allotment option was granted in connection with TROV’s previously announced public offering of 1,150,000 units. The company’s gross proceeds from the offering totaled $10,580,000.

Leave a Reply




You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

All stories in are for informational purposes only. This is NOT a stock recommendation. This story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at . About is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.